SEQENSgroup
SEQENS R&D Center in Porcheville, France, confirms its status as a center of excellence On 21 January 2019, the French National Agency for…
Read moreEmergence of a new global CDMO Three custom development and manufacturing organizations – PCAS S.A. in France, Chemie Uetikon in Germany and PCI…
Read moreSuppliers are the lifeblood of drug development and manufacturing. Whether the project requires off-the-shelf or customized ingredients, a reliable supply of high quality…
Read moreAt PCI Synthesis, we are committed to quality control throughout every aspect of our operations. Critical to the quality of our NCEs, generic…
Read moreCongratulations! Clinical trials have proven successful and now on to the next major decision as you prepare for product launch: finding the right…
Read morePCI Synthesis, Inc. (www.pcisynthesis.com), a manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products based within…
Read moreTHE PAST FEW YEARS have seen the rise of a major player in pharmaceutical CDMO services in Seqens. The name is pronounced like…
Read more